Last reviewed: June 28, 2026
Last updated: June 28, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works through a straightforward dosing schedule: one subcutaneous injection per week, typically administered on the same day each week for consistency. Unlike daily medications, this once-weekly frequency reduces pill burden and improves adherence, while clinical studies show sustained weight loss averaging 15% of baseline body weight over 68 weeks of treatment.
Understanding Semaglutide Injection Frequency and Administration
Semaglutide is delivered as a single subcutaneous injection once every seven days, making it one of the most convenient GLP-1 delivery methods available. You choose a consistent day each week—such as Monday morning or Friday evening—and inject the medication into your abdomen, thigh, or upper arm using a pre-filled pen. This predictable weekly schedule eliminates the need to remember daily dosing and allows your body to establish a stable medication rhythm.
The injection itself takes less than one minute, and most patients report minimal discomfort due to the thin needle gauge. PlexusDx sources semaglutide from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality with the same active ingredient found in brand-name formulations. Your compounded semaglutide injection begins at $149 per month, with no flat per-compound pricing increases as your therapeutic dose advances over time.
Semaglutide Dose Escalation Protocol: What to Expect Week by Week
Semaglutide follows a gradual dose-escalation schedule designed to minimize nausea and gastrointestinal side effects while your body adjusts to the medication. Treatment typically begins at a low starting dose, then increases in modest increments over four to five weeks until reaching your target maintenance dose. This titration approach—sometimes called a 'ramp-up'—allows your GLP-1 receptors to become sensitized to the drug's effects without overwhelming your system.
Most patients begin noticing appetite suppression within the first 2–3 weeks, though full weight loss momentum often builds during weeks 4–8 as your body adapts to increased doses. Your healthcare provider monitors your response, tolerability, and any emerging side effects during this escalation phase and may adjust timing based on your individual experience. This personalized approach helps ensure sustainable results without unnecessary discomfort or discontinuation.
By week 8–12, most patients reach their therapeutic maintenance dose and enter the steady-state phase, where weekly injections continue at a consistent level. During this period, weight loss typically accelerates, with many patients experiencing 1–2 pounds per week of fat loss. The predictable rhythm of once-weekly dosing makes it easy to build the habit into your routine, supporting long-term adherence.
Timeline for Weight Loss Results on Semaglutide Therapy
Weight loss on semaglutide follows a phase-based timeline that many patients can anticipate. Weeks 1–4 typically involve minimal scale changes but significant appetite reduction and food-craving shifts; some patients lose 2–5 pounds during this period. Weeks 5–8 mark the acceleration phase, where weekly weight loss of 1–1.5 pounds becomes common as your dose increases and your body's metabolic state adapts to sustained GLP-1 signaling.
Months 3–6 represent the momentum phase, during which patients often achieve 15–20% of their baseline weight loss and notice substantial changes in how clothes fit and how they feel during physical activity. By month 6–12, many patients approach a weight-loss plateau—a normal physiological response—and may benefit from lifestyle intensification (increased protein intake, strength training, stress management) or evaluation for adjunctive approaches like PlexusDx's GLP-Squared dual-compound option.
Individual timelines vary based on starting weight, metabolic health, diet quality, exercise engagement, and genetic factors that influence GLP-1 and GLP-2 receptor sensitivity. PlexusDx offers the Precision Peptide Genetic Test—a peptide-pathway assessment examining variants in GLP1R (rs6923761), GIPR (rs1800437), MC4R (rs17782313), and FTO (rs9939609) genes—to reveal your unique response likelihood and help optimize therapy from the outset.
Managing Side Effects and Optimizing Your Semaglutide Experience
Common side effects during the dose-escalation phase include mild nausea, reduced appetite (which is therapeutic), and occasional constipation or fatigue. These effects typically peak during dose increases and diminish within 3–5 days as your body equilibrates. Practical strategies—eating smaller, protein-rich meals; staying hydrated; and taking medications with food when appropriate—help most patients navigate this adjustment smoothly and remain compliant with their treatment protocol.
Staying consistent with your weekly injection schedule amplifies the medication's effectiveness and stability; missing doses or irregular timing can trigger hunger rebound and reduce overall efficacy. PlexusDx integrates semaglutide dosing into a comprehensive weight-loss framework that includes dietary guidance, activity tracking, and behavioral coaching to address the non-pharmacological drivers of long-term success. If side effects become intolerable or weight loss plateaus unexpectedly, your PlexusDx provider can evaluate whether dose adjustment, compound switching (such as to oral semaglutide or tirzepatide), or addition of a second agent may be warranted.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How often do I inject semaglutide, and can I skip a week if I miss a dose?
Semaglutide is injected once per week on the same day each week for optimal results. If you miss a dose, inject it as soon as you remember, then resume your normal schedule the following week. Skipping doses or delaying injections for more than a few days can reduce medication effectiveness and may trigger hunger rebound.
What is the starting dose of semaglutide, and how high can it go?
Semaglutide typically begins at a low starting dose and escalates in small increments over 4–5 weeks. Most patients reach a therapeutic maintenance dose by week 8–12, and some continue modest increases if medically appropriate. Your PlexusDx provider personalizes the escalation based on your tolerability and weight-loss response.
Can I use semaglutide if I have Type 2 diabetes or prediabetes?
Yes, semaglutide is approved and commonly used for both weight loss and glycemic control in people with Type 2 diabetes or prediabetes. The medication improves insulin sensitivity and blood glucose levels while promoting weight loss, making it a dual-benefit therapy. Discuss your diabetes history with your PlexusDx provider to ensure semaglutide aligns with your overall health goals.
How much does compounded semaglutide injection cost at PlexusDx, and does price increase with dose?
PlexusDx compounded semaglutide injection starts at $149 per month across all therapeutic doses, with no your dose may need to go up - your price won't advances. This flat-rate pricing—"Your dose may need to go up. Your price won't."—ensures predictable, affordable access to weight-loss therapy without surprise cost escalation.
Can genetic testing help predict how well I'll respond to semaglutide?
Yes. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month) which examines GLP-1 receptor variants (GLP1R rs6923761) and related peptide-pathway genes to reveal your genetic predisposition for GLP-1 response. This insight helps your provider optimize your treatment approach from the start.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Happens to Weight When You Stop Ozempic: Understanding the Transition
Is It Better to Inject Zepbound in Stomach or Thigh?